Search
Apimeds Pharmaceuticals US Inc
APUSAdd to Watchlist
0.900USD
+0.005+0.58%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
11.32MMarket Cap
LossP/E TTM
Apimeds Pharmaceuticals US Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-0.55
-359.11%
Analyst Rating
--
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Apimeds Pharmaceuticals US Inc?
According to Apimeds Pharmaceuticals US Inc's FY2025 earnings report, its current assets were 13.98M, with a year-on-year change of 106998.56.
What are the total assets of Apimeds Pharmaceuticals US Inc?
According to Apimeds Pharmaceuticals US Inc's FY2025 earnings report, its total assets of Apimeds Pharmaceuticals US Inc were 164.18M, with a year-on-year change of 1257338.43.
What are the total liabilities of Apimeds Pharmaceuticals US Inc?
According to Apimeds Pharmaceuticals US Inc's FY2025 earnings report, its total liabilities of Apimeds Pharmaceuticals US Inc were 10.84M, with a year-on-year change of 690.26.
What is the total equity of Apimeds Pharmaceuticals US Inc?
According to Apimeds Pharmaceuticals US Inc's FY2025 earnings report, its total equity of Apimeds Pharmaceuticals US Inc was 153.35M, with a year-on-year change of 11391.18.
What is the net financing of Apimeds Pharmaceuticals US Inc?
According to Apimeds Pharmaceuticals US Inc's FY2025 earnings report, its net financing of Apimeds Pharmaceuticals US Inc was 20.62M, with a year-on-year change of 6215.26.
What is the Earnings Per Share (EPS) of Apimeds Pharmaceuticals US Inc?
According to Apimeds Pharmaceuticals US Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.55, with a year-on-year change of -359.11.
What is the debt-to-asset ratio of Apimeds Pharmaceuticals US Inc?
According to Apimeds Pharmaceuticals US Inc's FY2025 earnings report, its debt-to-asset ratio was 4.62, with a year-on-year change of -99.90.
What is the Return on Assets (ROA) of Apimeds Pharmaceuticals US Inc?
According to Apimeds Pharmaceuticals US Inc's FY2025 earnings report, its Return on Assets (ROA) was -7.31, with a year-on-year change of 98.86.
What is the operating profit of Apimeds Pharmaceuticals US Inc?
According to Apimeds Pharmaceuticals US Inc's FY2025 earnings report, its operating profit was -11.91M, with a year-on-year change of -834.25.